< Back to Search

Neurology® Podcast - November 19 2013 Issue

Fibroblast growth factor-21 is a sensitive biomarker of mitochondrial disease

1) Fibroblast growth factor-21 being a sensitive biomarker of mitochondrial disease and 2) Topic of the month: Area of functional symptoms and conversion disorder. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. James Addington interviews Dr. Carolyn Sue about her paper on fibroblast growth factor-21 being a sensitive biomarker of mitochondrial disease. Dr. Roy Strowd is reading our e-Pearl of the week about MAD for seizures. In the next part of the podcast Dr. Shanna Patterson intervi Read More

Download this Episode

Episode Segments

Introduction

00:19 00:50

Play Segment

Interview-Fibroblast growth factor-21 is a sensitive biomarker of mitochondrial disease

ePearl 1-MAD for seizures

LOTW-functional neurologic symptoms and how to discuss this diagnosis with patients

11:19 20:12

Play Segment

MeSH Terms

ePearl 2-MAD for seizures

Closing

21:03 23:09

Play Segment

Top

FOR MORE INFORMATION

Email pbaskin@neurology.org

Footer